Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
32.98
+0.59 (1.82%)
Dec 15, 2025, 4:00 PM EST - Market closed
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of $1.88 billion as of December 16, 2025. Its market cap has increased by 202.16% in one year.
Market Cap
1.88B
Enterprise Value
1.56B
1-Year Change
202.16%
Ranking
Category
Stock Price
$32.98
Market Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has increased from $804.46M to $1.88B, an increase of 134.16%. That is a compound annual growth rate of 14.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 1.85B | 216.66% |
| Dec 31, 2024 | 584.23M | 148.73% |
| Dec 29, 2023 | 234.88M | -35.46% |
| Dec 30, 2022 | 363.95M | -58.77% |
| Dec 31, 2021 | 882.62M | -60.67% |
| Dec 31, 2020 | 2.24B | 142.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |